78
Views
4
CrossRef citations to date
0
Altmetric
Editorial

What is the future for drug development in atherosclerosis and dyslipidaemia?

Pages 1-3 | Published online: 15 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Keith Suckling. (2012) The landscape of drug discovery in atherosclerosis and dyslipidaemia revisited: an update of patenting activity. Expert Opinion on Therapeutic Patents 22:3, pages 199-204.
Read now
Keith E Suckling. (2009) Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic. Expert Opinion on Investigational Drugs 18:10, pages 1425-1430.
Read now
John A Vernon. (2009) Considering the economic principles of pharmaceutical R&D. Expert Opinion on Drug Discovery 4:1, pages 21-22.
Read now

Articles from other publishers (1)

Keith Suckling. (2010) Phospholipase A2s: Developing drug targets for atherosclerosis. Atherosclerosis 212:2, pages 357-366.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.